SG Americas Securities LLC Purchases 1,623 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

SG Americas Securities LLC increased its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 37.7% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,924 shares of the company’s stock after acquiring an additional 1,623 shares during the period. SG Americas Securities LLC’s holdings in U.S. Physical Therapy were worth $547,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in USPH. Harbor Capital Advisors Inc. raised its position in U.S. Physical Therapy by 292.5% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 7,584 shares of the company’s stock worth $701,000 after buying an additional 5,652 shares during the last quarter. Cetera Advisors LLC bought a new position in U.S. Physical Therapy in the first quarter valued at about $214,000. Silvercrest Asset Management Group LLC purchased a new position in U.S. Physical Therapy in the first quarter worth about $8,158,000. Advisors Asset Management Inc. grew its stake in shares of U.S. Physical Therapy by 78.4% during the 1st quarter. Advisors Asset Management Inc. now owns 1,056 shares of the company’s stock valued at $119,000 after purchasing an additional 464 shares during the period. Finally, CANADA LIFE ASSURANCE Co increased its position in shares of U.S. Physical Therapy by 5.8% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 12,642 shares of the company’s stock valued at $1,423,000 after purchasing an additional 696 shares during the last quarter.

U.S. Physical Therapy Trading Down 0.2 %

Shares of NYSE:USPH opened at $84.04 on Tuesday. The stock has a 50 day moving average of $93.37 and a 200 day moving average of $99.65. The company has a market cap of $1.27 billion, a PE ratio of 68.33, a price-to-earnings-growth ratio of 3.17 and a beta of 1.38. U.S. Physical Therapy, Inc. has a 12-month low of $78.08 and a 12-month high of $113.63. The company has a current ratio of 1.88, a quick ratio of 2.16 and a debt-to-equity ratio of 0.28.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The firm had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $163.34 million. During the same period last year, the company earned $0.76 earnings per share. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. As a group, equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.85 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 13th. Stockholders of record on Friday, August 23rd will be given a $0.44 dividend. The ex-dividend date of this dividend is Friday, August 23rd. This represents a $1.76 annualized dividend and a dividend yield of 2.09%. U.S. Physical Therapy’s payout ratio is 143.09%.

Insider Transactions at U.S. Physical Therapy

In related news, CEO Christopher J. Reading sold 2,900 shares of the business’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $100.26, for a total value of $290,754.00. Following the transaction, the chief executive officer now directly owns 95,838 shares of the company’s stock, valued at approximately $9,608,717.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, CEO Christopher J. Reading sold 1,100 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $102.13, for a total transaction of $112,343.00. Following the completion of the transaction, the chief executive officer now owns 99,738 shares in the company, valued at $10,186,241.94. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Christopher J. Reading sold 2,900 shares of U.S. Physical Therapy stock in a transaction dated Thursday, May 30th. The stock was sold at an average price of $100.26, for a total value of $290,754.00. Following the completion of the sale, the chief executive officer now directly owns 95,838 shares in the company, valued at $9,608,717.88. The disclosure for this sale can be found here. Corporate insiders own 1.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on USPH shares. Barrington Research dropped their price objective on shares of U.S. Physical Therapy from $122.00 to $108.00 and set an “outperform” rating on the stock in a report on Thursday, August 15th. StockNews.com downgraded shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Tuesday, August 13th. One research analyst has rated the stock with a sell rating and three have issued a buy rating to the stock. Based on data from MarketBeat, U.S. Physical Therapy has a consensus rating of “Moderate Buy” and an average price target of $112.50.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.